ESR2 and neoplasm: Estrogen receptors α and β (i.e., ERα and ERβ) play a differential role in prostate cancer development: overexpression of ERα cuases the tumor oncogene effect and, in contrast, overexpression of ERβ could induce the tumor suppressor effect (25, 26).